A detailed history of Evergreen Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Evergreen Capital Management LLC holds 21,697 shares of AZN stock, worth $1.37 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,697
Previous 20,231 7.25%
Holding current value
$1.37 Million
Previous $1.58 Million 7.17%
% of portfolio
0.06%
Previous 0.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $112,398 - $128,450
1,466 Added 7.25%
21,697 $1.69 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $84,848 - $102,654
1,270 Added 6.7%
20,231 $1.58 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $16,172 - $18,436
265 Added 1.42%
18,961 $1.28 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $49,326 - $55,216
797 Added 4.45%
18,696 $1.26 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $54,149 - $59,869
-835 Reduced 4.46%
17,899 $1.21 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $115,701 - $125,465
1,655 Added 9.69%
18,734 $1.34 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $29,238 - $33,150
463 Added 2.79%
17,079 $1.19 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $10,191 - $13,242
188 Added 1.14%
16,616 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $42,309 - $108,328
798 Added 5.11%
16,428 $901,000
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $100,030 - $120,084
1,688 Added 12.11%
15,630 $1.03 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $100,518 - $121,084
1,804 Added 14.86%
13,942 $925,000
Q4 2021

Mar 11, 2022

BUY
$54.02 - $63.83 $107,013 - $126,447
1,981 Added 19.5%
12,138 $707,000
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $98,007 - $107,233
1,764 Added 21.02%
10,157 $610,000
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $72,339 - $89,908
1,494 Added 21.66%
8,393 $503,000
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $101,865 - $117,590
2,160 Added 45.58%
6,899 $343,000
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $6,889 - $8,238
142 Added 3.09%
4,739 $237,000
Q3 2020

Nov 16, 2020

BUY
$53.07 - $61.1 $21,440 - $24,684
404 Added 9.64%
4,597 $252,000
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $180,718 - $231,914
4,193 New
4,193 $222,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $195,563 - $265,632
-5,175 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $11,549 - $13,725
272 Added 5.55%
5,175 $258,000
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $196,708 - $222,939
4,903 New
4,903 $219,000
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $253,363 - $307,119
-7,139 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $263,143 - $296,197
7,139 New
7,139 $271,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.